泛素
计算生物学
机制(生物学)
计算机科学
转化式学习
转化研究
生物
数据科学
蛋白质降解
蛋白质组
领域(数学)
泛素蛋白连接酶类
可转让性
免疫系统
泛素连接酶
内质网相关蛋白降解
生物信息学
工程伦理学
分类
认知科学
小脑
约束(计算机辅助设计)
神经科学
钥匙(锁)
风险分析(工程)
作者
Nuofan Wu,Zihui Xu,Shuhong Dai,Qianqian Wang
标识
DOI:10.3389/fphar.2026.1815569
摘要
Proteolysis-targeting chimeras (PROTACs) have emerged as a transformative modality within the targeted protein degradation (TPD) landscape, inducing spatial proximity between E3 ubiquitin ligases and proteins of interest (POIs) to hijack the ubiquitin-proteasome system (UPS). Unlike traditional occupancy-driven inhibitors, this catalytic, event-driven mechanism enables the targeting of historically "undruggable" proteomes and circumvents acquired resistance. However, the field faces formidable challenges, including suboptimal pharmacokinetic profiles, the stoichiometric "hook effect," and a disproportionate reliance on a limited pool of E3 ligases (notably cereblon (CRBN) and von Hippel-Lindau (VHL)). This review critically examines PROTAC core principles and provides a nuanced functional categorization across oncology, immune modulation, neurodegenerative diseases, and basic research. We further evaluate three pivotal technical strategies-degrader architecture innovations, conditional activation modalities, and advanced delivery platforms-while systematically appraising current clinical progress. Finally, we discuss key limitations and future translational directions, aiming to provide a realistic roadmap for the next-generation of TPD therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI